Emsam FDA Approval History
FDA Approved: Yes (First approved February 27, 2006)
Brand name: Emsam
Generic name: selegiline
Dosage form: Transdermal System
Company: Somerset Pharmaceuticals, Inc.
Treatment for: Depression
Emsam is a transdermal patch containing the monoamine oxidase inhibitor selegiline. Emsam is indicated for the treatment of major depressive disorder (MDD) in adults.
Development Timeline for Emsam
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.